[1]
“Velcade® Safety and Effectiveness Study: A Case Series of Seven Filipino Adult Patients Diagnosed with Relapsed or Refractory Multiple Myeloma”, Acta Med Philipp, vol. 48, no. 1, Mar. 2014, doi: 10.47895/amp.v48i1.1207.